ClinicalTrials.gg
Drug

Lasmiditan clinical trials

Also written LY573144.

studies test it
32
open now
0
in phase 3
7
first study started
2006

How each study uses lasmiditan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
11 Oct 2019 · REYVOW · NDA 211280 (FDA, Drugs@FDA)
European Union
17 Aug 2022 · Rayvow · EMEA/H/C/005332 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Lasmiditan
25
Lasmiditan 200 mg
4
Lasmiditan 100 mg
2

Development codes

LY573144
29
COL-144
1

Studies by the year they started

32 studies that test it; most in 2017 (12)

Studies that test lasmiditan, by start year
YearStudies
20061
20091
20111
20153
20161
201712
20183
20195
20203
20212

By phase

A phase 1/2 study counts in both.

Phase 1
22
Phase 2
3
Phase 3
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 32 · Other 0

Eli Lilly and Company (30) · IlDong Pharmaceutical Co Ltd (2)

Often tested with

Tested in the same studies.

Sumatriptan (2) · Rosuvastatin (1) · Propranolol (1) · Topiramate (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses lasmiditan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 32

See all 32 studies that test lasmiditan →

Codes

What other systems call lasmiditan · ClinicalTrials.gg INT005761

  • MeSH (NLM) C554777lasmiditanConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 760I9WM792LASMIDITANConfirmed FDA, NLM, Wikidata
  • RxNorm 2256930One source FDA
  • Wikidata Q6493750lasmiditanConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166996LasmiditanOne source FDA
  • DrugBank DB11732One source Wikidata

Also registered as lasmiditan succinate (UNII W64YBJ346B).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.